Fagron NV
XBRU:FAGR

Watchlist Manager
Fagron NV Logo
Fagron NV
XBRU:FAGR
Watchlist
Price: 18.24 EUR -0.33% Market Closed
Market Cap: 1.3B EUR
Have any thoughts about
Fagron NV?
Write Note

Net Margin
Fagron NV

9.5%
Current
9%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
9.5%
=
Net Income
77.9m
/
Revenue
820.8m

Net Margin Across Competitors

Country BE
Market Cap 1.3B EUR
Net Margin
10%
Country US
Market Cap 77.7B USD
Net Margin
1%
Country US
Market Cap 48.9B USD
Net Margin
1%
Country US
Market Cap 48.4B USD
Net Margin
1%
Country US
Market Cap 30.3B USD
Net Margin
1%
Country US
Market Cap 9.3B USD
Net Margin
3%
Country CN
Market Cap 65B CNY
Net Margin
8%
Country KR
Market Cap 12.2T KRW
Net Margin
7%
Country CN
Market Cap 65.4B HKD
Net Margin
1%
Country CN
Market Cap 60.9B CNY
Net Margin
1%
Country IT
Market Cap 5.5B EUR
Net Margin
7%
No Stocks Found

Fagron NV
Glance View

Market Cap
1.3B EUR
Industry
Health Care

Fagron NV engages in the development, marketing, and distribution of healthcare products and services. The company is headquartered in Nazareth, Oost-Vlaanderen and currently employs 3,061 full-time employees. The company went IPO on 2007-10-05. The company operates as a research and development (R&D) scientific pharmaceutical compounding supplier and operates through four segments: The Fagron Specialty Pharma Services segment comprises personalized medication that is produced in the Company's compounding facilities; the Fagron Trademarks segment encompasses concepts and formulations developed by the Company's research and development (R&D) team; Fagron Essentials comprises pharmaceutical raw materials, equipment and supplies for pharmacies, and the HL Technology segment includes the development and production of precision components and orthopedic tools for dental and medical professionals.

FAGR Intrinsic Value
26.29 EUR
Undervaluation 31%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
9.5%
=
Net Income
77.9m
/
Revenue
820.8m
What is the Net Margin of Fagron NV?

Based on Fagron NV's most recent financial statements, the company has Net Margin of 9.5%.